Medicare Monthly Premiums to Drop for Seniors
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Millions of seniors who had to pay high...
Read More
Hematology/Oncology
Recurrent Non-Small Cell Lung Cancer with Circulating Free and Extracellular Vesicles-Derived Microrna as A Prognostic Biomarker
The most common cancer-related fatality is non-small cell lung cancer (NSCLC). A successful...
Read More
Radiographers Read Mammograms for UK Double Reading Program
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Trained radiographers perform as well as...
Read More
Triplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
MONDAY, Sept. 26, 2022 (HealthDay News) — Triplet therapy of cabozantinib + nivolumab +...
Read More
Metachronous Pathology Assessed in Young-Onset CRC Survivors
TUESDAY, Sept. 27, 2022 (HealthDay News) — The incidence rate of clinically significant...
Read More
Apixaban Noninferior to Enoxaparin for Postoperative VTE Prophylaxis
TUESDAY, Sept. 27, 2022 (HealthDay News) — Apixaban is noninferior to enoxaparin for...
Read More
Adenoma Detection Rate Tied to CRC Risk After Positive FIT
TUESDAY, Sept. 27, 2022 (HealthDay News) — The adenoma detection rate (ADR) of endoscopists...
Read More
Novel Therapeutics in Uterine Sarcoma Treatment
Uterine sarcomas are representative of the variety of sarcomas overall. The 3 histologies that are...
Read More
uLMS Women: Clinical Features & Treatment Outcomes
For a study, researchers sought to determine the clinical features and treatment results of women...
Read More
1358O Clinical Qualification of Transcriptome Signatures for APC Starting ADT with or without AAP
Standard of treatment for APC is adding AAP to ADT (metastatic, M1 & high-risk non-metastatic,...
Read More
1274P Performance Status & EOL Care in mPC Patients Treated with ART Therapy
One of the main goals of palliative care was to lessen the burden of treatment (tx), particularly...
Read More
Odds of Fair/Poor Health Up for Low-Income Cancer Survivors
MONDAY, Sept. 26, 2022 (HealthDay News) — Low-income cancer survivors have increased odds of...
Read More
Concurrent High PD-L1 Expression & CD8+ IC Infiltration
Researchers found that in advanced epidermal growth factor receptor (EGFR)-mutant non-small cell...
Read More
NSCLC Patients’ Survival Treated With ICI Monotherapy
Researchers found that overall survival (OS) in patients with advanced-stage non-small cell lung...
Read More
Dostarlimab Treatment of Advanced or Recurrent Endometrial Cancer with Mismatch Repair Deficiency or Microsatellite Instability
Patient-reported outcome evaluations were becoming more popular to learn about potential new drugs...
Read More
917P OPTIMA: Improve Care for Patients with Prostate, Breast, And Lung Cancer Through Artificial Intelligence
The Innovative Medicines Initiative (IMI) 2 sponsored public-private research initiative OPTIMA...
Read More
A Plasma Exosome AKR1C3 mRNA Expression Marker in Metastatic Prostate Cancer Patients Is Predictive and Prognostic
A key player in the course of prostate cancer and a possible biomarker for metastatic...
Read More
Outcomes May Be Better for Warfarin Users Who Stop Aspirin Use
FRIDAY, Sept. 23, 2022 (HealthDay News) — Cutting aspirin use among patients treated with...
Read More
Physician Burnout Significantly Increased During 2020 to 2021
FRIDAY, Sept. 23, 2022 (HealthDay News) — A dramatic increase in burnout occurred in U.S....
Read More
Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Neoadjuvant therapy with a novel hormonal agent...
Read More